Development System
PDCD1_site_16 | SCGE Toolkit
Database of study and experiment data generated by the Somatic Cell Genome Editing Consortium
A novel human T cell platform to define biological adverse effects of genome editing |
PDCD1_site_16 |
Calculated editing efficiency by targeted amplicon deep sequencing |
|
Editing Efficiency |
15000000511 |
|
SpCas9 |
P3 Nucleofection Kit |
Commercial Reagent |
PDCD1_site_16 |
|
|
Human |
CD4/CD8 Human Primary T cell |
|
nucleofection |
|
75 pmol Cas9 protein; 3-fold molar excess of sgRNA |
|
|
|
|
ribonucleoprotein (RNP) |
|
|
|
Measured Values |
Samples Size: | 3 |
|
Mean |
36.92  |
1 |
34.643321897551196  |
2 |
39.4182568334193  |
3 |
36.7016705443417  |
| |
|
Publication Title |
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. NCBI |